Stephen Bruehl Selected Research

Naloxone (Narcan)

1/2021	Does aerobic exercise training alter responses to opioid analgesics in individuals with chronic low back pain? A randomized controlled trial.
12/2020	Are endogenous opioid mechanisms involved in the effects of aerobic exercise training on chronic low back pain? A randomized controlled trial.
3/2019	The association between endogenous opioid function and morphine responsiveness: a moderating role for endocannabinoids.
1/2017	Psychosocial factors predict opioid analgesia through endogenous opioid function.
1/2017	Endogenous Opioid Function and Responses to Morphine: The Moderating Effects of Anger Expressiveness.
1/2017	Ethnic Differences in the Effects of Naloxone on Sustained Evoked Pain: A Preliminary Study.
1/2016	Expectancy Effects on Conditioned Pain Modulation Are Not Influenced by Naloxone or Morphine.
5/2014	Relationship between endogenous opioid function and opioid analgesic adverse effects.
3/2014	Endogenous opioid inhibition of chronic low-back pain influences degree of back pain relief after morphine administration.
9/2013	Endogenous opioid function mediates the association between laboratory-evoked pain sensitivity and morphine analgesic responses.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen Bruehl Research Topics

Disease

70	Pain (Aches) 10/2022 - 09/2002
33	Chronic Pain 01/2022 - 09/2002
26	Low Back Pain (Lumbago) 01/2021 - 09/2002
17	Acute Pain 01/2022 - 09/2002
9	Back Pain (Backache) 01/2021 - 11/2002
7	Complex Regional Pain Syndromes 10/2022 - 08/2003
5	Wounds and Injuries (Trauma) 06/2022 - 01/2019
4	Postoperative Pain 01/2021 - 11/2003
3	Opioid-Related Disorders (Opiate Addiction) 11/2020 - 07/2015
3	Fibromyalgia (Fibrositis) 12/2018 - 01/2016
2	Osteoarthritis 05/2022 - 01/2022
2	Knee Osteoarthritis 01/2021 - 03/2013
2	Neuralgia (Stump Neuralgia) 10/2019 - 01/2019
1	Reperfusion Injury 05/2022
1	Edema (Dropsy) 01/2022
1	Flushing 01/2022
1	Ischemia 01/2022
1	Reflex Sympathetic Dystrophy (Reflex Sympathetic Dystrophy Syndrome) 01/2022
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2019
1	Overactive Urinary Bladder (Overactive Bladder) 10/2018
1	Rheumatoid Arthritis 07/2018
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2016
1	Temporomandibular Joint Disorders (Temporomandibular Joint Disorder) 01/2016
1	Headache (Headaches) 01/2016
1	Mental Disorders (Mental Disorder) 01/2016
1	Hypesthesia (Numbness) 05/2014
1	Pruritus (Itching) 05/2014
1	Hypertension (High Blood Pressure) 02/2013
1	Coma (Comas) 04/2010

Drug/Important Bio-Agent (IBA)

43	Opioid Analgesics (Opioids)IBA 06/2022 - 09/2002
18	Analgesics (Analgesic Drugs)IBA 03/2022 - 10/2006
18	Naloxone (Narcan)FDA LinkGeneric 01/2021 - 09/2002
15	Pharmaceutical PreparationsIBA 01/2021 - 09/2002
12	Morphine (MS Contin)FDA LinkGeneric 01/2021 - 09/2013
11	Pain-FreeIBA 12/2018 - 09/2002
6	Anesthetics (Anesthetic Agents)IBA 01/2019 - 04/2010
6	aminoalcoholphosphotransferase (AAPT)IBA 01/2019 - 03/2014
4	Naltrexone (ReVia)FDA LinkGeneric 03/2022 - 12/2009
4	Narcotic Antagonists (Opioid Antagonists)IBA 12/2020 - 09/2013
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2022 - 01/2017
3	Complement System Proteins (Complement)IBA 01/2021 - 01/2017
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 03/2022 - 01/2021
2	InterleukinsIBA 01/2022 - 01/2017
2	Capsaicin (Zostrix)FDA Link 12/2021 - 01/2017
2	Type A Botulinum Toxins (Botox)FDA Link 10/2018 - 01/2017
2	mu Opioid Receptors (mu Opioid Receptor)IBA 10/2008 - 04/2006
2	Yohimbine (Yocon)IBA 08/2008 - 02/2008
2	Adrenergic Agents (Adrenergic Drugs)IBA 08/2008 - 02/2008
2	CatecholaminesIBA 11/2004 - 08/2003
1	cyclopropapyrroloindoleIBA 03/2022
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Corn Oil (Oil, Corn)IBA 01/2022
1	CytokinesIBA 01/2022
1	Interleukin-4 (Interleukin 4)IBA 01/2022
1	EnzymesIBA 01/2022
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2022
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2022
1	ImmunosorbentsIBA 01/2022
1	prostaglandin-inositol cyclic phosphateIBA 01/2022
1	IsoprostanesIBA 01/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2021
1	ElementsIBA 01/2021
1	Oxycodone (Oxycontin)FDA LinkGeneric 11/2020
1	Ibuprofen (Motrin)FDA LinkGeneric 11/2020
1	Acetaminophen (Paracetamol)FDA LinkGeneric 11/2020
1	A-Form DNA (A-DNA)IBA 10/2019
1	EndocannabinoidsIBA 03/2019
1	anandamide (arachidonylethanolamide)IBA 03/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Biological ProductsIBA 01/2019
1	trichostatin A (A 300)IBA 07/2018
1	Indicators and Reagents (Reagents)IBA 09/2017
1	Interleukin-12 (IL 12)IBA 01/2017
1	Chemokine CCL26IBA 01/2017
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2017
1	Interleukin-2 (IL2)IBA 01/2017
1	Interleukin-13IBA 01/2017
1	EndorphinsIBA 01/2017
1	Blood Glucose (Blood Sugar)IBA 04/2015
1	Antihypertensive Agents (Antihypertensives)IBA 02/2013
1	Neurotransmitter Agents (Neurotransmitter)IBA 02/2013
1	Diphosphonates (Bisphosphonates)IBA 04/2010
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2010
1	Ketamine FDA LinkGeneric 04/2010
1	BuffersIBA 12/2009
1	alpha-2 Adrenergic ReceptorsIBA 02/2008
1	beta-Endorphin (Endorphin, beta)IBA 08/2007

Therapy/Procedure

15	Analgesia 03/2022 - 09/2002
6	Knee Replacement Arthroplasty (Total Knee Replacement) 10/2022 - 11/2003
6	Therapeutics 10/2019 - 11/2003
1	Tourniquets 05/2022
1	Operative Surgical Procedures 01/2022
1	Bathroom Equipment 01/2022
1	Radiofrequency Ablation 01/2021
1	Complementary Therapies (Alternative Medicine) 11/2020
1	Tonsillectomy 11/2020
1	Surgical Amputation (Amputations) 10/2019
1	Precision Medicine 02/2013
1	Spinal Cord Stimulation 04/2010